GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,414 | -51.7% | 2,870 | -34.0% | 0.00% | -100.0% |
Q2 2023 | $19,475 | +58915.2% | 4,347 | -36.5% | 0.00% | 0.0% |
Q1 2023 | $33 | +43.5% | 6,844 | -4.3% | 0.00% | 0.0% |
Q4 2022 | $23 | -99.9% | 7,152 | +35.9% | 0.00% | – |
Q3 2022 | $17,000 | +466.7% | 5,261 | +634.8% | 0.00% | – |
Q2 2022 | $3,000 | +50.0% | 716 | +20.7% | 0.00% | – |
Q1 2022 | $2,000 | -71.4% | 593 | -49.3% | 0.00% | – |
Q4 2021 | $7,000 | +75.0% | 1,170 | +110.8% | 0.00% | – |
Q3 2021 | $4,000 | – | 555 | +670.8% | 0.00% | – |
Q2 2021 | $0 | – | 72 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 96,232 | $716,000 | 0.96% |
CM Management, LLC | 64,327 | $479,000 | 0.36% |
Greenlight Capital | 546,560 | $4,069,000 | 0.27% |
Indie Asset Partners, LLC | 29,652 | $221,000 | 0.18% |
PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $433,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $372,000 | 0.01% |
Veritable, L.P. | 25,064 | $187,000 | 0.00% |
Banque Cantonale Vaudoise | 3,000 | $22,000 | 0.00% |
MORGAN STANLEY | 800 | $6,000 | 0.00% |
BlackRock Inc. | 11,476 | $85,000 | 0.00% |